Telephone Conference. Members may participate in and hold a meeting by means of conference telephone or similar communications equipment by means of which all Persons participating in the meeting can hear each other, and participation in such meeting shall constitute attendance and presence in person at such meeting, except where a Person participates in the meeting for the express purpose of objecting to the transaction of any business on the ground that the meeting is not lawfully called or convened.
Telephone Conference. Unitholders may participate in and hold a meeting by means of conference telephone or similar communications equipment by means of which all Persons participating in the meeting can hear each other, and participation in such meeting shall constitute attendance and presence in person at such meeting, except where a Person participates in the meeting for the express purpose of objecting to the transaction of any business on the ground that the meeting is not lawfully called or convened.
Telephone Conference. The Members may participate in and hold a meeting of the Members by means of conference telephone or other similar communications equipment pursuant to which all persons participating in the meeting can hear each other. Subject to Section 4.8, participation in a meeting pursuant to this section constitutes presence in person at such a meeting.
Telephone Conference. Managers may participate in a meeting of the Board of Managers or any committee thereof through the use of conference telephone or similar communications equipment; provided, that all of the Managers participating in such meeting can communicate with each other. Participation in a meeting pursuant to this Section 6.3(e) shall constitute presence at the meeting for all purposes.
Telephone Conference. On the occasion of today’s Interim Report we have the pleasure to invite investors and journalists to the following informative meeting during the day The conference starts at 15:00 (CET) To participate, please call + 00 (0)0 000 000 00 An operator will note your name and connect you to the conference. She/he will also provide you with information about what to do if you have any questions. The presentation will be held in English but afterwards there will be an opportunity to ask questions in Swedish. Participating on behalf of Precise Biometrics Xxxxxx Xxxxxxxxx, President and CEO Xxxxxx Xxxxxxx, CFO A recording from the conference will be available for three days after the telephone meeting. To listen to the conference afterwards dial +00 (0)0 000 000 00. When asked to state a reference number please dial 348860 and finish with (#). Please visit xxx.xxxxxxxxxxxxxxxxx.xxx/xxxxxxxxx-xxxxxxx where a presentation can be downloaded. FOR FURTHER INFORMATION Xxxxxx Xxxxxxx, CFO, Precise Biometrics AB Tel. +00 00 00 00 00 or +00 000 00 00 00 E-mail xxxxxx.xxxxxxx@xxxxxxxxxxxxxxxxx.xxx Precise Biometrics AB (headquarters) Box 798 SE-220 07 Lund Interim Report E-mail: xxxx@xxxxxxxxxxxxxxxxx.xxx Precise Biometrics is a market-leading provider of solutions for fingerprint recognition to prove people's identities. With top- of-the-line expertise in fingerprint verification, Precise Biometrics offers fast, accurate and secure authentication of a person. The technology adds value to ID, enterprise and bank cards as well as access to mobile solutions, computers and networks. Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 160 million users.
Telephone Conference. CEO Xxxxxxxx XxXxxxxxx and CFO Xxxx Xxxxxxxxx will be available for questions at 9.30 a.m. CET. Please call: • Sweden: +00 (0)0 000 000 00 • UK + 00 (0)000 000 0000 • USA: +0 000 000 00 00 Swedish Orphan Biovitrum (Sobi) The information above has been published pursuant to the Swedish 3 Market Act and/or the Financial Instruments Trading Act. The
Telephone Conference. An audiocast and telephone conference will be held today at 14.00 CET. Participants: Xxxxxxxx Xxxxxxxx, CEO of Oasmia Xxxx Xxxxxxx, Member of the Board and former acting CEO of Oasmia Xxxx Xxx, CEO of Elevar Therapeutics Inc Xxxx XxXxxxxx, Vice President Commercial and Business Development of Elevar Therapeutics Inc Link to audiocast: xxxxx://xx.xxxxxxxxxxxxxx.xxx/2020-03-25-press-conference Dial-in numbers telephone conference: FR: +00000000000 SE: +00000000000 UK: +000000000000 US: +00000000000 For more information: Urban Ekelund IR Manager Oasmia Phone: +00 00-00 00 00 E-mail: XX@xxxxxx.xxx About Oasmia Pharmaceutical AB Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. Product development aims to produce novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives. Product development is based on Oasmia’s proprietary technology platform XR17. Oasmia has been successful in driving its first product candidate, Apealea® (paclitaxel micellar), through clinical development, and has applied for and achieved market approval in the European Union and other territories. Oasmia is in the process of transitioning into the commercialization phase of the product Apealea® and making the product accessible to patients via its partnership with Elevar and its existing operations and partnerships in its retained territories. Advisors EVOLUTION Life Science Partners LLC, a division of Gordian Investments, LLC acted as advisor to Oasmia Pharmaceutical AB. Latham&Watkins LLP served as Oasmia’s legal advisor on the transaction and WilsonSonsini LLP served as legal advisor to Elevar Therapeutics. [1] Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Ukraine and Uzbekistan This information is information that Oasmia Pharmaceutical is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2020-03-25 07:00 CET.
Telephone Conference. Members of the Board of Directors or any committee thereof may participate in a meeting of the Board or such committee initiated in Maryland by means of a conference telephone or similar communications equipment, by means of which all persons participating in the meeting can hear each other at the same time. Participation by such means shall constitute presence in person at the meeting.
Telephone Conference. Subject to the requirements of the Act or this Agreement for notice of meetings, the Managers or members of any committee designated by the Board may participate in and hold a meeting of the Board or any committee, as the case may be, by means of a conference telephone or similar communications equipment by means of which all individuals participating in the meeting can hear each other, and participation in such meeting shall constitute attendance and presence in person at such meeting, except where an individual participates in the meeting solely for the express purpose of objecting to the transaction of any business on the ground that the meeting is not lawfully called or convened.
Telephone Conference. Except as provided in the Investment Company -------------------- Act of 1940, Trustees may participate in any regular or special meeting of the Trustees by means of a conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other at the same time and participation by such means shall constitute presence in person at a meeting.
